Neutrophil-to-Lymphocyte Ratio Can Distinguish Cystitis From OAB

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 8, 2024 -- Serum neutrophil-to-lymphocyte ratio (NLR) can help differentiate interstitial cystitis/bladder pain syndrome (IC/BPS) from overactive bladder (OAB), according to a study published online Nov. 8 in BMC Urology.

Hanwei Ke, from Peking University People's Hospital in Beijing, and colleagues conducted a retrospective analysis involving 70 women diagnosed with IC/BPS, 20 diagnosed with OAB, and a randomly selected cohort of 150 healthy women (normal). All participants underwent a comprehensive panel of blood tests, and the NLR was determined.

The researchers observed significant differences in the NLR levels among the IC/BPS, normal, and OAB groups. Notably divergent NLR levels were demonstrated in Hunner type IC (HIC) compared with non-Hunner type IC (NHIC) within the IC/BPS group. Positive correlations were also seen between NLR and nighttime voids, the Interstitial Cystitis Problem Index, Interstitial Cystitis Symptom Index, Pelvic Pain and Urgency/Frequency questionnaire (PUF), and PUF Symptom Scale. The area under the receiver operating characteristic curve analysis for NLR was 0.765 and 0.707 for distinguishing IC/BPS from the normal group and IC from OAB, respectively, and was 0.723 for differentiating HIC and NHIC patients.

"Our study underscores the link between heightened NLR and the symptomatology and onset of IC/BPS, underscoring the potential of NLR as a diagnostic marker for IC/BPS," the authors write. "Given the ongoing diagnostic debates surrounding IC/BPS, NLR can offer valuable support in the diagnostic process."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-09 04:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords